![Mark O’Mahony](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark O’Mahony
Geen lopende functies
Vermogen: 31 075 $ op 31-05-2026
Profiel
Mark O’Mahony formerly worked at Millennium Pharmaceuticals, Inc., as Principal in 2000, LeukoSite, Inc., as Principal in 2000, Tolerx, Inc., as VP-Process Development & Manufacturing from 2000 to 2011, DecImmune Therapeutics, Inc., as Vice President-Manufacturing & Quality, Serono Corp., as Principal, and Leap Therapeutics, Inc., as Vice President-Manufacturing from 2011 to 2020.
Mr. O’Mahony received his Masters Business Admin degree from Boston University and undergraduate degree from University College Dublin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-03-2025 | 27.500 ( 0,03% ) | 31 075 $ | 31-05-2026 |
Eerdere bekende functies van Mark O’Mahony
| Bedrijven | Functie | Einde |
|---|---|---|
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Corporate Officer/Principal | 19-12-2011 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Corporate Officer/Principal | 01-01-2000 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01-01-2000 |
| CYPHERPUNK TECHNOLOGIES INC. | Corporate Officer/Principal | - |
DecImmune Therapeutics, Inc.
 DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation | Corporate Officer/Principal | - |
Opleiding van Mark O’Mahony
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
DecImmune Therapeutics, Inc.
DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Serono Corp. | |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Kies MarketScreener 
